The exact frequency of repeated therapy needed to achieve optimal results for each condition is unknown and decided on a patient to patient basis. We expect those who are otherwise healthy and are undergoing regenerative therapies to optimize their long-term health to receive a plasma exchange procedure once every 2 – 6 months based on their response to the initial Therapeutic Plasma Exchange treatment.
Individuals suffering from Alzheimer’s in large multi-national, multi-center, randomized placebo-controlled trials where benefit was shown, followed a protocol of 4-6 plasma exchange procedures done weekly followed by once a month plasma exchange to slow, stop, and even reverse the process of neurodegeneration. We use this standard as a starting point and customize according to individual patient response. We also use this protocol as a foundation for approaching patients with other neurodegenerative and age-associated conditions in the hopes of slowing down symptom progression and reversing degenerative processes.
Individuals who are highly biologically burdened with auto-antibodies, toxins, mis-folded proteins, signals of senescence, and cellular debris are expected to need a higher frequency of repeated procedures. In the case of acutely ill patients with Guilian-Barre this frequency may be daily. However, in the outpatient setting, individuals with chronic degenerative disease need far fewer such procedures.